Lung cancer remains the leading cause of cancer mortality worldwide. Immunotherapy has recently emerged as a promising therapeutic strategy both for ...

Lung cancer outcomes have improved only marginally over the last 40 years and remain dismally poor in comparison to most other cancers: only 17.7% of women and 12.9% of men in the UK survive after ...

Lung cancer commonly spreads to organs such as the brain and bones. Learn why — and how to spot signs and symptoms of metastatic lung cancer. How Lung Cancer Spreads: Tracking Metastasis Paths ...

Small cell lung cancer (SCLC), accounting for 10–20% of lung cancers, remains one of the most aggressive neuroendocrine malignancies, with fewer than 7% of ... Shirasawa et al. directly links DLL3High ...

Lung cancer is one of the most frequently diagnosed cancers and the leading cause of cancer-related deaths worldwide with an estimated 2 million new cases and 1·76 million deaths per year. Substantial ...

Clinical study results demonstrated that CyPath® Lung had 92% sensitivity, 87% specificity and 88% accuracy in detecting lung cancer in patients at high risk for the disease who had small lung ...

Prior to the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting, I put together a preview article focused on the biotech-related stories coming out of the various oral presentations ...

This question can be hurtful, because it implies the person deserved to get the disease. The fact is, as many as 20 percent of people who die of lung cancer each year have never smoked or used any ...

CHICAGO -- The bispecific T-cell engager tarlatamab (Imdelltra) significantly prolonged survival in the second-line treatment of small cell lung cancer (SCLC), a practice-changing phase III trial ...

Background Lung cancer outcomes in the UK are worse than in many other developed nations. Symptom awareness campaigns aim to diagnose patients at an earlier stage to improve cancer outcomes. Methods ...

Tip Sheet: A new treatment for metastatic colorectal cancer, discoveries for small cell lung cancer — and a state-of-the-art learning lab for community education SEATTLE — June 4, 2025 — Below are ...